- Investing Ideas
- /
- Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
18
Companies with a Value score of at least 3, ordered by Value score
18 companies
Merck
Market Cap: AR$199.2b
Operates as a healthcare company worldwide.
MRK
AR$21,200.00
7D
-4.4%
1Y
-21.6%
Gilead Sciences
Market Cap: AR$129.1b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
AR$34,650.00
7D
-3.5%
1Y
91.3%
Biogen
Market Cap: AR$16.9b
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
BIIB
AR$11,875.00
7D
-4.6%
1Y
-26.4%
Bristol-Myers Squibb
Market Cap: AR$103.2b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
AR$22,550.00
7D
-10.2%
1Y
29.5%
Bristol-Myers Squibb
Market Cap: US$103.2b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMYD
US$20.50
7D
0%
1Y
n/a
Pfizer
Market Cap: AR$124.3b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFE
AR$7,310.00
7D
-4.9%
1Y
5.5%
Bayer
Market Cap: AR$19.8b
Operates as a life science company worldwide.
BAYN
AR$3,323.26
7D
0%
1Y
n/a
Biogen
Market Cap: US$16.9b
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
BIIBD
US$9.91
7D
0%
1Y
n/a
Merck
Market Cap: US$199.2b
Operates as a healthcare company worldwide.
MRKD
US$15.50
7D
-4.6%
1Y
-44.8%
Novartis
Market Cap: AR$163.4b
Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.
NVS
AR$36,075.00
7D
2.6%
1Y
43.4%
Novartis
Market Cap: US$163.4b
Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.
NVSD
US$26.50
7D
0%
1Y
10.2%
Pfizer
Market Cap: US$124.3b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFED
US$5.46
7D
-4.4%
1Y
-20.8%
GSK
Market Cap: US$52.5b
Engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSKD
US$8.43
7D
-2.3%
1Y
n/a
Gilead Sciences
Market Cap: US$129.1b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILDD
US$26.00
7D
-10.3%
1Y
49.9%
GSK
Market Cap: AR$52.5b
Engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
AR$11,475.00
7D
-4.2%
1Y
6.1%
Instituto Rosenbusch
Market Cap: AR$3.6b
Manufactures and sells veterinary products in Argentina.
ROSE
AR$84.10
7D
-14.2%
1Y
-17.5%
Amgen
Market Cap: US$153.8b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGND
US$9.60
7D
-4.0%
1Y
-1.5%
Amgen
Market Cap: AR$153.8b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
AR$12,800.00
7D
-2.5%
1Y
35.2%